VANCOUVER, Jan. 17 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ:QLTI;
TSX:QLT) today reported that Novartis AG announced global sales of QLT's
Visudyne(R) (verteporfin) product of US$45.5 million for the quarter and
US$214.9 million for the full year ended December 31, 2007. Visudyne sales
for the fourth quarter declined by 40.5% over the same quarter in 2006 and
the full year represented a decrease of 39.3% over annual sales in 2006.
Visudyne sales in the U.S. for the quarter were approximately US$10
million, representing 22% of total sales for the quarter. U.S. average
daily Visudyne sales increased to 127 vials in the fourth quarter of 2007
compared to 118 vials in the third quarter of 2007. The growth in daily
Visudyne vial sales translates to a US$0.6 million increase quarter over
quarter.

QLT will release its full financial results on Thursday, February 21,
2008, at 7:30 a.m. Eastern Time (ET).

QLT Inc. is a global biopharmaceutical company dedicated to the
discovery, development and commercialization of innovative therapies. Our
research and development efforts are focused on pharmaceutical products in
the fields of ophthalmology and dermatology. In addition, we utilize three
unique technology platforms, photodynamic therapy, Atrigel(R) and punctal
plugs with drugs, to create products such as Visudyne(R) and Eligard(R) and
future product opportunities. For more information, visit our web site at
http://www.qltinc.com.

Conference call information

QLT Inc. will hold an investor conference call to discuss year end
results for 2007 on Thursday, February 21 at 8:30 a.m. ET (5:30 a.m. PT).
The call will be broadcast live via the Internet at http://www.qltinc.com. To
participate on the call, please dial 1-800-319-4610 (North America) or
604-638-5340 (International) before 8:30 a.m. ET. A replay of the call will
be available via the Internet and also via telephone at 1-800-319-6413
(North America) or 604-638-9010 (International), access code 7142, followed
by the number sign.

A full explanation of how QLT determines and recognizes revenue
resulting from Visudyne sales is contained in the financial statements
contained in the periodic reports on Forms 10-Q and 10-K, under the heading
"Significant Accounting Policies - Revenue Recognition." Visudyne sales are
product sales by Novartis under its agreement with QLT.

Atrigel is a registered trademark of QLT USA, Inc.

Visudyne is a registered trademark of Novartis AG.

Eligard is a registered trademark of Sanofi-Synthelabo Inc.

QLT Inc. is listed on The NASDAQ Stock Market under the trading symbol

"QLTI" and on The Toronto Stock Exchange under the trading symbol "QLT."

The Visudyne(R) sales figures in this press release are preliminary and

(Date:9/26/2017)... , ... September 26, 2017 , ... “Good Morning Sunshine!: ... healing, and overcoming obstacles. “Good Morning Sunshine!: Finding Strength and Comfort in God” is ... in psychology from Fort Hays Sate University, who has worked at a local mental ...

(Date:9/26/2017)... ... September 26, 2017 , ... “Sound of My Song”: an intriguing and ... published author, Karmen Worden, a retired teacher with a passion for music and ancestral ... intriguing and inspiring story on loss, living with depression, and finding love through the ...

(Date:9/26/2017)... ... September 26, 2017 , ... “Sonflower Submission”: a relatable and concise ... inevitable destinations of negativity, complaining and the need to always be correct. There comes ... order for a lesson in stress-less living to be learned. “Sonflower Submission” is ...

(Date:9/26/2017)... ... , ... “The Lion, the Lamb, and the Rose”: a charming tale of three animals, each ... the Lamb, and the Rose” is the creation of published author, Ieshia Greaves, a mother ... that this book touches the hearts of children and adults, there is a lesson for ...

(Date:9/26/2017)... ... ... Time out for Daddy is a moving story of a family's unconditional love ... “Time Out for Daddy” is the creation of published author Debra Titus, who has ... children inspired her to write this book. , Published by Christian Faith Publishing, Debra ...

(Date:9/13/2017)... -- OrthoAtlanta has been named the official orthopedic and ... for the 2018 College Football Playoff (CFP) National Championship to ... in Atlanta, Georgia . OrthoAtlanta is proud ... participating in many activities leading up to, and including the ... ...